Correction: Mobilization studies in mice deficient in sphingosine kinase 2 support a crucial role of the plasma level of sphingosine-1-phosphate in the egress of hematopoietic stem progenitor cells
Metrics: PDF 1584 views | ?
1 Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA
2 Department of Regenerative Medicine, Warsaw Medical University, Warsaw, Poland
3 Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY, USA
4 Department of Pharmacology University of Virginia, Charlottesville, VA, USA
5 Department of Chemistry, Center for Drug Discovery, Virginia Tech, Blacksburg, VA, USA
Published: September 25, 2018
This article has been corrected: The correct Acknowledgments and Funding is provided below:
ACKNOWLEDGMENTS AND FUNDING
This work was supported by NIH grants 2R01 DK074720-10 and R01HL112788, the Stella and Henry Endowment, and the Harmonia NCN grant UMO-2014/14/M/NZ3/00475 to MZR, the Preludium NCN grant UMO-2016/23/N/NZ4/03345 to MA, R01GM121075 to KRL and WLS and the UK COBRE Early Career Program (P20 GM103527) to AAL. MA supported by the Foundation for Polish Science (FNP).
Original article: Oncotarget. 2017; 8:65588-65600. DOI: https://doi.org/10.18632/oncotarget.19514.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.